A carregar...
Cardiac mesenchymal cells from failing and nonfailing hearts limit ventricular dilation when administered late after infarction
Although cell therapy-mediated cardiac repair offers promise for treatment/management of heart failure, lack of fundamental understanding of how cell therapy works limits its translational potential. In particular, whether reparative cells from failing hearts differ from cells derived from nonfailin...
Na minha lista:
| Publicado no: | Am J Physiol Heart Circ Physiol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Physiological Society
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7474443/ https://ncbi.nlm.nih.gov/pubmed/32442025 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpheart.00114.2020 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|